Council for Innovation Promotion

Publish Date
Reports
Overview of the USPTO Drug Exclusivity Report
Council for Innovation Promotion Statement on House Introduction of the Nurture Originals, Foster Art, and Keep Entertainment Safe (NO FAKES) Act of 2024

WASHINGTON (September 12, 2024) — Today, Reps. María Elvira Salazar (R-FL), Madeleine Dean (D-PA), Nathaniel Moran (R-TX), Adam Schiff (D-CA), Rob Wittman...

New Op-Ed from Judge (ret.) Kathleen O’Malley: The AI revolution is coming for artists — laws need to catch up

C4IP board member and retired federal judge Kathleen O’Malley recently published a new opinion piece in World Intellectual Property Review on how...

Council for Innovation Promotion Celebrates the Introduction of PERA in the House of Representatives

WASHINGTON (September 6, 2024) — Today, Representatives Kevin Kiley (R-CA) and Scott Peters (D-CA) introduced the Patent Eligibility Restoration Act (PERA) in...

C4IP Coalition Updates: August 2024

August was a productive month for C4IP! Here’s a roundup of all that we accomplished over the past month. August Highlights: Supporting...

This Month in IP: August 2024

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From frozen...

Congress should restore the rights SCOTUS stripped from patent owners
The Hill
Section 101 Patent Eligibility Roundup: It’s Been Too Long
Mondaq
Fact Check: The USPTO’s Proposed Requirement for Filing Terminal Disclaimers Would Weaken Patent Rights

On May 9, 2024, the USPTO issued a notice of proposed rulemaking adding a new requirement for filing terminal disclaimers, which are...

Big Tech wants to keep stealing patents—so it’s going to war with Big Pharma

C4IP Co-Chairs and former USPTO Directors Andrei Iancu and David Kappos recently published an opinion piece in Fortune about how Big Tech...

Fortune
Section 101 Patent Eligibility Roundup: It’s Been Too Long
Lexology
Letters
C4IP Letter to Senate HELP Committee on the Medication Affordability and Patent Integrity Act

Dear Chairman Sanders and Ranking Member Cassidy: I write on behalf of the Council for Innovation Promotion (C4IP) to voice our organization’s...

Resources:

Resources:

Overview of the USPTO Drug Exclusivity Report,

09/12/2024

Press Releases:

Press Releases:

Council for Innovation Promotion Statement on House Introduction of the Nurture Originals, Foster Art, and Keep Entertainment Safe (NO FAKES) Act of 2024,

09/12/2024

Op-Eds:

Op-Eds:

New Op-Ed from Judge (ret.) Kathleen O’Malley: The AI revolution is coming for artists — laws need to catch up,

09/06/2024

Press Releases:

Press Releases:

Council for Innovation Promotion Celebrates the Introduction of PERA in the House of Representatives,

09/06/2024

Blog:

Blog:

C4IP Coalition Updates: August 2024,

08/31/2024

Blog:

Blog:

This Month in IP: August 2024,

08/31/2024

Op-Eds:

Op-Eds:

Congress should restore the rights SCOTUS stripped from patent owners,

08/29/2024

News:

News:

Section 101 Patent Eligibility Roundup: It’s Been Too Long,

08/29/2024

Blog:

Blog, Fact Checks:

Fact Check: The USPTO’s Proposed Requirement for Filing Terminal Disclaimers Would Weaken Patent Rights,

08/28/2024

Op-Eds:

Blog, Op-Eds:

Big Tech wants to keep stealing patents—so it’s going to war with Big Pharma,

08/28/2024

News:

News:

Section 101 Patent Eligibility Roundup: It’s Been Too Long,

08/27/2024

Resources:

Resources:

C4IP Letter to Senate HELP Committee on the Medication Affordability and Patent Integrity Act,

08/26/2024

Scroll to Top